Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
Macerelli M, Caramella C, Faivre L, Besse B, Planchard D, Polo V, Ngo Camus M, Celebic A, Koubi-Pick V, Lacroix L, Pignon JP, Soria JC.
Macerelli M, et al. Among authors: polo v.
Lung Cancer. 2014 Mar;83(3):383-8. doi: 10.1016/j.lungcan.2013.12.013. Epub 2014 Jan 3.
Lung Cancer. 2014.
PMID: 24439569